These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29441734)

  • 1. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.
    Spitali P; Hettne K; Tsonaka R; Sabir E; Seyer A; Hemerik JBA; Goeman JJ; Picillo E; Ergoli M; Politano L; Aartsma-Rus A
    J Cell Mol Med; 2018 Apr; 22(4):2442-2448. PubMed ID: 29441734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
    Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
    Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic and morphometrical study of the muscle spindle in muscular dystrophy.
    Kararizou EG; Manta P; Kalfakis N; Gkiatas KA; Vassilopoulos D
    Anal Quant Cytol Histol; 2007 Jun; 29(3):148-52. PubMed ID: 17672374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miRNAs as biomarkers for the rare types of muscular dystrophy.
    Koutsoulidou A; Koutalianos D; Georgiou K; Kakouri AC; Oulas A; Tomazou M; Kyriakides TC; Roos A; Papadimas GK; Papadopoulos C; Kararizou E; Spyrou GM; Zamba Papanicolaou E; Lochmüller H; Phylactou LA
    Neuromuscul Disord; 2022 Apr; 32(4):332-346. PubMed ID: 35393236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary muscular dystrophies and the heart.
    Hermans MC; Pinto YM; Merkies IS; de Die-Smulders CE; Crijns HJ; Faber CG
    Neuromuscul Disord; 2010 Aug; 20(8):479-92. PubMed ID: 20627570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of dystrophinopathy by skin biopsy.
    Niiyama T; Higuchi I; Sakoda S; Matsumura T; Fukunaga H; Osame M
    Muscle Nerve; 2002 Mar; 25(3):398-401. PubMed ID: 11870717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies.
    Comim CM; Mathia GB; Hoepers A; Tuon L; Kapczinski F; Dal-Pizzol F; Quevedo J; Rosa MI
    An Acad Bras Cienc; 2015 Sep; 87(3):1809-18. PubMed ID: 25910175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
    Srivastava NK; Annarao S; Sinha N
    Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased bone mineral density in adult patients with muscular dystrophy.
    Philippe V; Pruna L; Abdel Fattah M; Pascal V; Kaminsky P
    Joint Bone Spine; 2011 Dec; 78(6):651-2. PubMed ID: 21727019
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
    Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
    Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy.
    von Moers A; Danne T; Möller P; Scheffner D
    Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies.
    Spitali P; Hettne K; Tsonaka R; Charrout M; van den Bergen J; Koeks Z; Kan HE; Hooijmans MT; Roos A; Straub V; Muntoni F; Al-Khalili-Szigyarto C; Koel-Simmelink MJA; Teunissen CE; Lochmüller H; Niks EH; Aartsma-Rus A
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):715-726. PubMed ID: 29682908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscular dystrophies and other genetic myopathies.
    Shieh PB
    Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular Dystrophies.
    Carter JC; Sheehan DW; Prochoroff A; Birnkrant DJ
    Clin Chest Med; 2018 Jun; 39(2):377-389. PubMed ID: 29779596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.
    Becker N; Moore SA; Jones KA
    Acta Neuropathol Commun; 2022 Feb; 10(1):17. PubMed ID: 35135626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadism is common in men with myopathies.
    Al-Harbi TM; Bainbridge LJ; McQueen MJ; Tarnopolsky MA
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):397-401. PubMed ID: 18525423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin is a serum biomarker for Duchenne muscular dystrophy.
    Cynthia Martin F; Hiller M; Spitali P; Oonk S; Dalebout H; Palmblad M; Chaouch A; Guglieri M; Straub V; Lochmüller H; Niks EH; Verschuuren JJ; Aartsma-Rus A; Deelder AM; van der Burgt YE; 't Hoen PA
    Proteomics Clin Appl; 2014 Apr; 8(3-4):269-78. PubMed ID: 24458521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.
    Mah JK; Korngut L; Fiest KM; Dykeman J; Day LJ; Pringsheim T; Jette N
    Can J Neurol Sci; 2016 Jan; 43(1):163-77. PubMed ID: 26786644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.